Testing TCA cream for low-grade cervical changes
Part of Cancer, Women’s health & pregnancy clinical trials.
This trial tests whether a topical cream called TCA (trichloroacetic acid) can effectively treat low-grade cervical lesions (LSIL) found after an abnormal Pap or HPV test. It may be an option for women who want to avoid more invasive procedures.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Women aged 18 to 65 years old.
- You have a colposcopy biopsy that showed CIN1 (mild cervical changes) or LSIL (low-grade lesion).
- Your abnormal result came from a low-grade screening test (like ASCUS with HPV positive, LSIL, HPV 16/18 positive, or persistent high-risk HPV).
- You are willing to take part in the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies a “conservative” (less immediate) approach to a specific abnormal cervix finding to see if it can be managed safely for people who want future pregnancies. It uses close follow-up visits instead of immediate procedures for certain results.
This study looks for ways to predict who will respond to imiquimod cream for precancerous cervical cell changes (CIN2 or CIN3). Results may help doctors choose the best treatment approach and better plan follow-up.
This study tests a light-activated therapy (HAL-PDT) to treat high-grade cervical dysplasia before considering surgery. It compares the response to standard surgery, aiming to see if the light therapy can help avoid or delay more invasive procedures.
This trial tests a new way to quickly diagnose and treat cervical pre-cancer using a point-of-care device. It may help women who are HPV-positive avoid a separate treatment visit.
This study tests a special light-based treatment (called HAL-PDT) for early cervical changes (CIN2) that were found on a recent biopsy. The goal is to see if this treatment can safely remove these changes and prevent them from becoming cancer.
This Phase 2 study tests whether a curcumin (a natural plant compound) cream/gel applied to the cervix can help treat cervical cell changes linked to HPV. It focuses on people with mild (LSIL) or recently treated severe (HSIL) precancer changes, aiming to reduce disease and improve healing.
Hear when a new Cervical Intraepithelial Neoplasia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.